SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17189541
Source:
http://linkedlifedata.com/resource/pubmed/id/17189541
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005910
,
umls-concept:C0019588
,
umls-concept:C0028754
,
umls-concept:C0032105
,
umls-concept:C0034693
,
umls-concept:C0041004
,
umls-concept:C0332281
,
umls-concept:C0442805
,
umls-concept:C0521390
,
umls-concept:C0547047
pubmed:issue
12
pubmed:dateCreated
2006-12-25
pubmed:abstractText
The purpose of the present study was to examine the metabolic effects of a specific histamine H(3) receptor antagonist, the cinnamic amide NNC 0038-0000-1202 (NNC 38-1202).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101264860
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Histamine
,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/NNC 38-1049
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Histamine H3
,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1930-7381
pubmed:author
pubmed-author:CremersThomasT
,
pubmed-author:GolozoubovaValeriaV
,
pubmed-author:JohansenPeter BPB
,
pubmed-author:MalmlöfKjellK
,
pubmed-author:PeschkeBerndB
,
pubmed-author:RefsgaardHanne H FHH
,
pubmed-author:RimvallKarinK
,
pubmed-author:WulffBirgitte SBS
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2154-62
pubmed:dateRevised
2008-1-21
pubmed:meshHeading
pubmed-meshheading:17189541-Administration, Oral
,
pubmed-meshheading:17189541-Animals
,
pubmed-meshheading:17189541-Body Weight
,
pubmed-meshheading:17189541-Dose-Response Relationship, Drug
,
pubmed-meshheading:17189541-Eating
,
pubmed-meshheading:17189541-Histamine
,
pubmed-meshheading:17189541-Histamine Antagonists
,
pubmed-meshheading:17189541-Male
,
pubmed-meshheading:17189541-Obesity
,
pubmed-meshheading:17189541-Paraventricular Hypothalamic Nucleus
,
pubmed-meshheading:17189541-Piperazines
,
pubmed-meshheading:17189541-Rats
,
pubmed-meshheading:17189541-Rats, Sprague-Dawley
,
pubmed-meshheading:17189541-Receptors, Histamine H3
,
pubmed-meshheading:17189541-Triglycerides
,
pubmed-meshheading:17189541-Weight Loss
pubmed:year
2006
pubmed:articleTitle
Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides.
pubmed:affiliation
Department of Diabetes Pharmacology, Novo Nordisk A/S, Novo Nordisk Park, 2760 Måløv, Denmark. kmal@novonordisk.com
pubmed:publicationType
Journal Article